Published 2006
| Version v1
Publication
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.
Additional details
- URL
- http://hdl.handle.net/11567/299935
- URN
- urn:oai:iris.unige.it:11567/299935
- Origin repository
- UNIGE